3,4-Dihydro-2H-benzo[b][1,4]oxazine-6-carboxylic acid, 97%, 500mg

2-(2-((Phenylsulfonyl)methyl)phenyl)-1,3-dioxolane, 95+%, 100mg

2-Methylpropylhydrazine hydrochloride, 95.0%, 1g

5-oxopyrrolidine-3-carbonitrile, 95.0%, 250mg

Tert-butyl(2r)-2-(4-methoxycarbonylphenyl)pyrrolidine-1-carboxylate, 98%, 1g

3-Bromo-6-chloro-imidazo[1,2-b]pyridazine, 99.0%, 25g

6-methoxy-2-(5-methyl-2-furanyl)-N-(1-methyl-4-piperidinyl)-7-[3-(1-pyrrolidinyl)propoxy]-4-quinolinamine, 10mg

5-[(2-methylpropyl)sulfanyl]-2,3-dihydro-1,3,4-thiadiazole-2-thione, 98%, 25g

(R)-Methyl 3-hydroxybutanoate, 97.0%, 5g

TERT-BUTYL 4,4-DIMETHYL-2,2-DIOXOOXATHIAZOLIDINE-3-CARBOXYLATE, 95.0%, 1g

6-Bromo-1H-indazole-3-carboxaldehyde, 95%, 250mg

Yoduro de potasio, mínimo 99,5 %, pa, ISO, 500 g, envase de vidrio

3-Chloro-5-cyanopicolinic acid, 95.0%, 250mg